Navigation Links
More Younger Women Diagnosed With Advanced Breast Cancer: Study
Date:2/27/2013

pe Comprehensive Cancer Center in Duarte, Calif., agreed. "The number of women [aged] 25 to 39 presenting with advanced breast cancer or any kind [of breast cancer] still remains relatively low, especially compared to women 40 and older," she said.

Lichtenfeld said the finding "emphasizes the importance of breast self-awareness, that no one knows your body better than you do."

Some younger women with symptoms may be dismissed by the doctor who sees them, Vito said. "It is not unusual for a woman who is 25 to 39 with a breast lump to have sought consultation with multiple doctors before getting an appropriate work-up," she said.

More information

To learn about early detection of breast cancer, visit the American Cancer Society.

SOURCES: Rebecca Johnson, M.D., medical director, adolescent and young adult oncology program, Seattle Children's Hospital, and assistant professor, pediatrics, University of Washington, Seattle; Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society; Courtney Vito, M.D., staff surgeon, general oncologic surgery, and assistant clinical professor, surgery, City of Hope Comprehensive Cancer Center, Duarte, Calif.; Feb. 27, 2013, Journal of the American Medical Association


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Study finds mammography beneficial for younger women
2. PSA screening to detect prostate cancer can be beneficial to younger and at-risk men
3. Female and younger athletes take longer to overcome concussions
4. ASCO: Younger colon cancer patients have worse prognosis at diagnosis, yet better survival
5. Miriam researchers urge physicians to ask younger men about erectile dysfunction symptoms
6. Younger Kids Likelier to Gain Weight After Tonsillectomy
7. Older and younger chronic leukemia patients may need different therapy
8. UC Davis study links low wages with hypertension, especially for women and younger workers
9. Younger Women Start to Follow Pap Test Guidelines: CDC
10. Active Video Games May Boost Fitness in Younger Students
11. Many Younger Parents Weigh Online Doctor Reviews: Poll
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
More Younger Women Diagnosed With Advanced Breast Cancer: Study
(Date:2/28/2015)... (PRWEB) February 28, 2015 Plugin creators ... TransFold Volume 2. A fully customizable transition ... “TransFold Volume 2 gives users total control over 30 ... Austin, CEO of Pixel Film Studios. “TransFold Volume 2 ... editor.” , TransFold Volume 2 from Pixel Film Studios ...
(Date:2/28/2015)... California (PRWEB) February 28, 2015 ... supported and showcased emerging brand at Houston Texas ... in Las Vegas sending its executive delegates headed ... of Business Development and Training Randolph Clarito. , ... (IFA), was held last February 4-7 and featured ...
(Date:2/27/2015)... A new study published in the Journal ... cycle on a regular basis and prostate cancer. While cycling ... the more hours per week a man spends cycling, the ... an increased importance on prostate cancer screening methods. , “This ... closely at patents’ risk factors for developing prostate cancer,” says ...
(Date:2/27/2015)... 2015 On March 2-4, the ... National Cancer Institute (NCI) will co-host the annual ... Institutes of Health (NIH), in Bethesda, Maryland. The ... to medical professionals and scientists who specialize in ... general public, including patients, their families, and caregivers. ...
(Date:2/27/2015)... February 27, 2015 Pipette.com announces their ... , price is only valid until the end of ... looking for a vortex mixer that allows for absolute ... founded in 1954 and is headquartered in Bohemia, New ... shakers, as well as other rockers, incubators, and hybridization ...
Breaking Medicine News(10 mins):Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2
... has joined Element,Six as head of E6 Ventures ... venture,business to identify and invest in new business ... Element Six has made significant,funds available to support ... an important enabling technology. The aim is to,provide ...
... - Online Resource to Support Journal Editors ... publisher of scientific, technical and,medical information products ... Publishing Ethics Resource Kit (PERK),( http://www.elsevier.com/publishingethicskit )., ... Conference in Singapore, Mark,Seeley, Senior Vice President ...
... More Than 50 percent of Americans Vitamin D Deficient, Dr. ... - but for Only 10 Minutes Weekly; Wear,Sunscreen With UVA ... CHARLESTON, S.C., March 4 As many as half of ... evidence shows a link,between low vitamin D levels and cancer, ...
... 4 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group (NYSE: SCR ... generic,pharmaceuticals and manufacturer of the patented anti-cancer biotech,product ... is a gold medal,winner of the 10th Outstanding ... Property Office of the People,s Republic of China,(SIPO)., ...
... of chronic obstructive pulmonary disease (COPD) should not be,screened ... from the U.S. Preventive Services Task Force. The,recommendation and ... Annals of Internal Medicine. It will appear in the ... is a lung disease in which the airways in ...
... of human embryonic stem cells (hESCs) also inhibits the ... cancer, Northwestern University researchers have discovered. Metastatic melanoma, which ... melanocytes, has a death rate of more than 80 ... months. , The Northwestern scientists, led by researcher ...
Cached Medicine News:Health News:Element Six Signals Ambitions for Growth With Senior Appointment for New Ventures Unit 2Health News:Elsevier Launches Publishing Ethics Resource Kit 2Health News:Renowned Doctor Says Best Way to Obtain Crucial Vitamin D Is From Sun; but Still, Don't Forget Sunscreen 2Health News:Renowned Doctor Says Best Way to Obtain Crucial Vitamin D Is From Sun; but Still, Don't Forget Sunscreen 3Health News:Endu Receives Gold Medal for Outstanding Chinese Patented Invention Award 2Health News:Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 2Health News:Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 3Health News:Protein in embryonic stem cells control malignant tumor cells 2Health News:Protein in embryonic stem cells control malignant tumor cells 3
(Date:2/27/2015)... OF PRUSSIA, Pa. , Feb. 27, 2015 /PRNewswire/ ... of its ongoing commitment to the global bleeding disorders ... is donating 2 million international units (IUs) of protein ... is an international not-for- profit organization which has worked ... other inherited bleeding disorders. The donation supports the WFH,s ...
(Date:2/27/2015)... N.J., Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... and reported financial results for the fourth quarter and ... "2014 was a transformative year for PTC. We are ... and developing RNA-targeted therapies in the rare disease space," ... Therapeutics, Inc. "We are proud to bring the first ...
(Date:2/27/2015)... 2015 ... kongestive Herzinsuffizienz (CHF) in seiner ersten klinischen ...   Die israelische Firma ... für Patienten mit kongestiver Herzinsuffizienz (CHF) entwickelt ... Finanzierungsvorhaben über 5 Mio. USD abgeschlossen hat. ...
Breaking Medicine Technology:CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2
... 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... and preventive vaccines against cancers and infectious diseases, announced ... journal Human Vaccines detailing potent immune responses ... for prostate cancer targeting two antigens. While current prostate ...
... (NYSE: BSX ) today announced financial results for the ... as net sales and earnings per share (EPS) guidance for the ... highlights: Reported sales of $2.002 billion with ... diluted share of $0.20. Increased year-over-year International ICD ...
Cached Medicine Technology:Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 2Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 3Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 4Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 5Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 2Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 3Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 4Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 5Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 6Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 7Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 8Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 9Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 10Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 11Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 12Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 13Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 14Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 15Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 16Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 17Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 18Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 19Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 20Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 21Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 22
... Inteq TFCC small joint ... of the triangular fibrocartilage ... capsule when peripheral separation ... system should be used ...
Low-profile hand-held instruments....
... The Mini Bio-Anchor with ... x 7 mm bioabsorbable implant ... pull-out strength. The bioabsorbable, PLDLA ... fixation strength throughout the tissue ...
... Fusion Screw is a headless ... of variable thread pitch and ... holding power. The Acutrak Fusion ... of the IP and DIP ...
Medicine Products: